Drug Approval | December 05, 2022
Zydus receives final approval from USFDA for Estradiol Transdermal System
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
The only definitive way to diagnose and stage lung cancers is through biopsies
Famotidine Injection is indicated to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed
Nifedipine Extended-Release Tablets have an estimated market size of US $56 million for twelve months ending September 2022
The approval further strengthens the Potassium Chloride franchise for the company.
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India
Ketorolac Tromethamine is advised for the short-term management of moderately severe acute pain in adult patients
Glenmark’s Sodium Phenylbutyrate Tablets USP, 500 mg, will be distributed in the U.S. by Glenmark Pharmaceuticals USA.
Subscribe To Our Newsletter & Stay Updated
